Medic Ice

Description

Medic Ice is represented by the ID Med1 and is associated with the image file named medicice.jpg, which is in JPEG format. The reference value for this product is also medicice.jpg.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the affected skin areas should be cleansed thoroughly to remove any other ointments, creams, sprays, or liniments prior to application. The medication should be applied directly to the affected areas no more than 3 to 4 times daily. After application, it is essential to wash hands to prevent accidental contact with the eyes and other sensitive areas. The medication may be used in conjunction with wet or dry bandages or with ice packs as needed.

For children under 2 years of age, it is advised to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

Application on wounds or damaged skin is prohibited due to the potential for irritation and delayed healing. The use of heating pads or heating devices concurrently is contraindicated as it may increase the risk of burns or skin irritation. Additionally, combining this product with other ointments, creams, sprays, or liniments is not recommended, as it may lead to adverse reactions or reduced efficacy. Finally, the application of this product under tight bandages is contraindicated, as it may cause excessive pressure and hinder proper skin function.

Warnings and Precautions

For external use only. This product is contraindicated for application on wounds or damaged skin. It should not be used in conjunction with heating pads or heating devices, nor should it be combined with other ointments, creams, sprays, or liniments. Additionally, the use of tight bandages is not recommended while using this product. Care should be taken to avoid contact with the eyes during application.

Healthcare professionals should advise patients to discontinue use and consult a physician if a rash develops, if the condition worsens, or if symptoms persist for more than 7 days. Patients should also seek medical advice if symptoms resolve and then recur within a few days.

It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. It is contraindicated for application on wounds or damaged skin, and should not be used in conjunction with heating pads, heating devices, other ointments, creams, sprays, or liniments, nor should it be applied under tight bandages.

During the use of this product, patients are advised to avoid contact with the eyes. If a rash appears, or if the condition worsens or symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, patients should discontinue use and consult a healthcare professional.

For those who are pregnant or breastfeeding, it is recommended to seek medical advice before using this product.

Drug Interactions

Co-administration of this medication with other topical formulations, including ointments, creams, sprays, or liniments, is contraindicated. The potential for altered efficacy or increased risk of adverse effects necessitates avoiding such combinations.

There are no specific interactions identified with laboratory tests associated with this medication. Therefore, no adjustments or special monitoring related to laboratory tests are required.

Packaging & NDC

Below are the non-prescription pack sizes of Medic Ice (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the affected skin should be cleaned of any other ointments, creams, sprays, or liniments prior to application. The medication may be applied directly to the affected areas no more than 3 to 4 times daily. It is important for caregivers to wash their hands after application to prevent contact with the eyes and sensitive areas. The medication can be used in conjunction with wet or dry bandages or with ice packs as needed.

Geriatric Use

Elderly patients may not have specific information regarding the use of Medic Ice - menthol gel, including dosage adjustments, safety concerns, or special precautions. As such, healthcare providers should exercise caution when prescribing this medication to geriatric patients.

Due to the absence of detailed data, it is advisable for clinicians to closely monitor elderly patients for any adverse effects or unusual responses to treatment. Individual patient factors, including comorbidities and concurrent medications, should be considered when determining the appropriateness of this therapy in the geriatric population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits associated with its use during pregnancy and lactation. The safety of this medication in pregnant women has not been established, and therefore, caution is advised.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is limited information available regarding the excretion of this drug in human breast milk and its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the substance involved in the overdose. Consultation with a poison control center or a medical toxicologist is recommended to guide the management of the patient effectively.

Overall, vigilance and prompt intervention are critical in managing cases of suspected overdose, even in the absence of detailed information regarding specific overdosage effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children and to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. Patients should be instructed not to apply the product on wounds or damaged skin, and to avoid using it in conjunction with heating pads or other heating devices.

It is important to inform patients that the product should not be used alongside other ointments, creams, sprays, or liniments, nor should it be applied under tight bandages. Patients should be counseled to discontinue use and consult a doctor if a rash develops, if the condition worsens, or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

Additionally, patients should be reminded to avoid contact with their eyes while using this product.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. The container must be kept tightly closed to prevent contamination and degradation. Additionally, the product should be protected from light exposure to ensure optimal stability. Once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

Patients aged 2 years and older are advised to apply the medication directly to the affected areas no more than 3 to 4 times daily. Clinicians should counsel patients to keep the product out of reach of children and to seek medical assistance or contact a Poison Control Center immediately if swallowed. Additionally, it is recommended that patients who are pregnant or breastfeeding consult a doctor prior to use.

Drug Information (PDF)

This file contains official product information for Medic Ice, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)